Biology subjects

Senapati, P.

Publications and source records attributed to Senapati, P..

11 recordsLinked to original sources

bioRxiv2026

PAD4-mediated histone citrullination contributes to enhanced NETosis in type 2 diabetes but not in type 1 diabetes

Neutrophil extracellular traps (NETs) are web-like structures released by activated neutrophils through a process known as NETosis, which help immobilize, trap, and eliminate invading pathogens. While NETs play a critical role in host defense, excessive or dysregulated NET formation can contribute to chronic inflammatory diseases such as diabetes and its complications. Elevated levels of NETs and increased expression of its mediator, protein-arginine deiminase type 4 (PAD4), have been reported in diabetes. However, the underlying molecular mechanisms governing the enhanced NETosis in type 1 (T1D) and type 2 diabetes (T2D) remain unclear. Using mouse models and human patient samples, we show that neutrophils undergo enhanced NETosis in T1D and T2D through distinct pathways. We found enhanced NETosis in T1D occurs in a PAD4-independent manner, driven by robust cytosolic ROS production by NADPH oxidase (NOX). This leads to myeloperoxidase activation and chromatin decondensation. We further confirm the PAD4 independent mechanism in neutrophils from STZ-induced PAD4-/- mice. In contrast, in T2D, neutrophils undergo NOX-independent NETosis, which relies on calcium-mediated mitochondrial ROS production, PAD4 activation, and hyper-histone citrullination. Taken together, our findings reveal previously uncharacterized distinct mechanisms of enhanced NETosis in T1D and T2D.

Molecular Biology↗

bioRxiv2025

T13F2.2 of C. elegans is Critical for Chromatin Organization, Autophagy, and Longevity

Intricately modulated by a spectrum of proteins, Chromatin structure governs gene expression and cellular homeostasis. In Caenorhabditis elegans, critical components like the TATA-binding protein tbp-1 play pivotal roles in orchestrating chromatin dynamics. While the function of many of the interacting partners of tbp-1 is well-understood, our study brings into focus a lesser-known entity, T13F2.2, an unexplored tbp-1 interacting protein and a putative RNA polymerase II transcriptional coactivator. Employing reverse genetics, we found that RNAi-induced depletion of T13F2.2 resulted in pronounced disruptions to nuclear architecture, evidenced by nuclear staining and transmission electron microscopy. Accompanying these structural anomalies, we observed increased autophagy, pointing to cellular stress and a hyperacetylation of the core histones, suggesting potential chromatin decompaction. Notably, multifaceted functional alterations, upon the partial knockdown of the T13F2.2, culminated in a substantial reduction in the worms lifespan. Intriguingly, interventions such as administering ROS scavengers and autophagy modulators offered a reprieve from this life-shortening effect. Transcriptomic analysis upon T13F2.2 knockdown revealed upregulation of genes related to autophagy and chromatin remodelling, alongside downregulation of genes involved in longevity pathways and oxidative stress response. This study, thus, not only puts forward the functional implication of an uncharacterized gene in C. elegans biology, but also further emphasizes the role of chromatin organization in aging at the organismal level.

genetics↗

bioRxiv2025

Single-Cell Multimodal Profiling Highlights Persistent Aortic Smooth Muscle Cell Changes in Diabetic Mice Despite Glycemic Control

BackgroundType 2 diabetes (T2D) is associated with accelerated vascular complications like hypertension and atherosclerosis. "Phenotypic switching" of vascular smooth muscle cells (SMC), a major driver of these complications, is enhanced in diabetes. Despite adequate glycemic control, SMC dysfunction can persist due to "metabolic memory" of prior hyperglycemia. However, the mechanisms of hyperglycemic memory associated with persistent SMC dysfunction are unclear. Here, leveraging single-cell (sc) multi-omics, we examined the effect of glucose normalization on transcriptomic and epigenomic changes associated with SMC phenotypic transition in T2D mice. MethodsWe treated T2D db/db mice with the antidiabetic drug dapagliflozin (DAPA) (db/dbDAPA) or vehicle (db/db), and non-diabetic control db/+ mice with vehicle for 6 weeks. Dissected aortas were subjected to scRNA-seq, scATAC-seq, and spatial transcriptomics (Xenium) to determine single-cell changes in gene expression and chromatin accessibility. ResultsDAPA treatment conferred effective glycemic control in db/db mice, with significant reductions in blood glucose/hemoglobin A1c. scRNA and scATAC-seq analysis of aortas identified major cell populations, including SMC, fibroblasts, endothelial and immune cells. SMC were further clustered into 9 subtypes, including contractile and fibromyocyte-like cells. Cell composition analysis revealed decreases in contractile SMC and increases in vascular remodeling associated fibromyocyte-like SMC in db/db versus db/+ mice. Interestingly, DAPA did not reverse diabetes-induced decreases in contractile markers but reversed changes in several fibromyocyte markers in db/db mice. Pseudotime trajectory analysis revealed increased activities of fibromyocyte enriched transcription factors (TFs) during contractile to fibromyocyte transition. Furthermore, increased expression of TFs regulating fibromyocyte phenotype (e.g. Atf4, Bach1, Hand2, Fosl2) in db/db were partially reversed by DAPA, whereas reduced contractile TF (Mef2c) expression was unchanged. Spatial transcriptomics analysis further mapped aortic cell types within intact aortas and confirmed that DAPA reversed alterations in key fibromyocyte but not contractile genes in db/db mouse aortas. ConclusionsPersistent epigenetic changes may contribute to sustained vascular remodeling and dysfunction in T2D. T2D reduced contractile SMC gene expression and related chromatin accessibility and promoted phenotypic transition to fibromyocytes. These changes are only partially reversed by a widely used antidiabetic drug like DAPA, underscoring the need for more effective therapies that target hyperglycemic memory.

biochemistry↗

bioRxiv2023

Stress-induced endogenous-dsRNAs drive beta-cells to IFN-I state

Aims/hypothesisEndogenous dsRNAs originating from retrotransposons within the human genome have the potential to trigger autoimmunogenic recognition via RIG-like receptors such as MDA5. This phenomenon, known as "viral mimicry", induces potent interferon-beta expression, resulting in cell death and potential collateral death to surrounding cells. Viral mimicry has been mostly studied in relation to epigenetic therapeutics, although there are indications the phenomenon is relevant in other physiological contexts. Here, we demonstrate that proinflammatory cytokine stress leads to the dysregulation of retrotransposons in human beta-cells, resulting in beta-cell death via viral mimicry. MethodsHuman islets from donors were treated with/without proinflammatory cytokines (IFN-{gamma}, TNF-, IL-1{beta}) and immunostained for dsRNA. Publicly available transcriptome and chromatin accessibility data from proinflammatory cytokine treated EndoC-{beta}H1 cells were analyzed to examine changes in transcriptional regulatory activity at retrotransposon loci. Transcriptome profiling experiments in 1.1B4 and MIN6 cells were performed to examine the generality of the results. Adenosine to inosine (A-to-I) editing was compared between sample groups to gauge the extent of RNA editing on dsRNAs. Additional transcriptome data from normal vs. type 1 diabetic human islets was also assessed for differences in A-to-I editing activity between sample groups. ResultsProinflammatory cytokine stress increases the amount of dsRNA in human islets, co-incident with cells that express insulin. In the EndoC-{beta}H1 human beta-cell line, proinflammatory cytokine stress leads to a substantial increase in transcription at RTE loci, including SINE/Alu elements and LINE elements, along with increased expression of RLRs (including MDA5), inflammatory transcription factors (e.g. IRF3, STAT1), and most critically, IFNB1, a potent instigator of type 1 interferon responses. Similar trends were observed in 1.1B4 and MIN6 cells. Gene ontology analysis revealed an enrichment of genes related to interferon signaling and inflammation. Inflammatory stress furthermore leads to an increase in chromatin accessibility at many RTE loci, with enrichment in a variety of RTE subfamilies (including L1, AluY, AluSp, AluSq2, and AluSc elements). Binding sites for inflammatory transcription factors, such as IRFs, are also enriched at these loci. While inflammatory stress increased the overall A-to-I editing events at Alu elements, the pool of total unedited Alus was increased upon inflammatory stress. Examination of A-to-I editing in RNA-seq data from type 1 diabetic human islets and normal controls revealed that editing in diabetic islets is dramatically lower ([~]1%) than islets from normal controls ([~]15%). Conclusions/interpretationTranscription and chromatin accessibility are both increased at RTEs (notably Alus) upon proinflammatory cytokine stress, accompanied by an increase in RLR expression and a shift to a type I interferon state, as indicated by increased IFNB1 and other interferon-stimulated genes, including MDA5, an RLR gene which is also a type 1 diabetes risk gene. The overall increase in A-to-I editing upon inflammatory stress is associated with increases in ADAR1 expression, yet the increase in overall unedited Alus shows that cytokine stress leads to a higher dsRNA burden in the beta-cell. This increase in dsRNA burden is further compounded by increased MDA5 expression, exacerbating the inflammatory state of the beta-cell. Comparisons of A-to-I editing between normal vs. type 1 diabetic human islets suggest that type 1 diabetics have more unedited dsRNAs, hindering their ability to prevent autoimmunogenic recognition. Research in contextWhat is already known about this subject? O_LICytokine stress during insulitis is a feature of autoimmune diabetes. C_LIO_LIStress-induced dysregulation of retrotransposons can lead to a dsRNA-based type-I interferon response in a variety of cells ( viral mimicry) C_LIO_LIEndogenous dsRNAs are subject to adenine to inosine (A-to-I) editing by ADAR1 to prevent self-recognition. C_LI What is the key question? O_LICan cytokine stress drive beta-cells into an IFN-I state via recognition of endogenous dsRNAs derived from retrotransposons that lose silencing under cytokine stress? C_LI What are the new findings? O_LICytokine stress causes an increase in dsRNAs derived from retrotransposons in beta-cells from human islets. C_LIO_LIThe SINE/Alu subset of these endogenous dsRNAs are less edited in stressed beta-cells, making them more self-recognizable. C_LIO_LIType 1 diabetic human islets exhibit more unedited Alus. C_LI How might this impact on clinical practice in the foreseeable future? O_LIInnate autoimmunity via endogenous dsRNAs can cause damage to beta-cells; therapies to target this pathway may help treat autoimmune diabetes. C_LI

molecular biology↗

bioRxiv2023

Identification of two β-cell subtypes by 7 independent criteria

Despite the recent explosion in surveys of cell-type heterogeneity, the mechanisms that specify and stabilize highly related cell subtypes remain poorly understood. Here, focusing initially on exploring quantitative histone mark heterogeneity, we identify two major sub-types of pancreatic {beta}-cells ({beta}HI and {beta}LO). {beta}HI and {beta}LO cells differ in their size, morphology, cytosolic and nuclear ultrastructure, transcriptional output, epigenomes, cell surface marker, and function. Importantly, {beta}HI and {beta}LO cells can be FACS separated live into CD24+ ({beta}HI) and CD24- ({beta}LO) fractions. From an epigenetic viewpoint, {beta}HI-cells exhibit [~]4-fold higher levels of H3K27me3, more compacted chromatin, and distinct chromatin organization that associates with a specific pattern of transcriptional output. Functionally, {beta}HI cells have increased mitochondrial mass, activity, and insulin secretion both in vivo and ex vivo. Critically, Eed and Jmjd3 loss-of-function studies demonstrate that H3K27me3 dosage is a significant regulator of {beta}HI / {beta}LO cell ratio in vivo, yielding some of the first-ever specific models of {beta}-cell sub-type distortion. {beta}HI and {beta}LO sub-types are conserved in humans with {beta}HI-cells enriched in human Type-2 diabetes. These data identify two novel and fundamentally distinct {beta}-cell subtypes and identify epigenetic dosage as a novel regulator of {beta}-cell subtype specification and heterogeneity. HighlightsO_LIQuantitative H3K27me3 heterogeneity reveals 2 common {beta}-cell subtypes C_LIO_LI{beta}HI and {beta}LO cells are stably distinct by 7 independent sets of parameters C_LIO_LIH3K27me3 dosage controls {beta}HI / {beta}LO ratio in vivo C_LIO_LI{beta}HI and {beta}LO cells are conserved in humans and enriched in Type-2 diabetes C_LI

cell biology↗

bioRxiv2022

Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility

Effects from aging in single cells are unpredictable, whereas aging phenotypes at the organ- and tissue-levels tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages, the luminal epithelial and myoepithelial cells. Mammary epithelia exhibit substantial stereotypical changes with age that merits attention because they are putative breast cancer-cells-of-origin. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increases susceptibility to cancer initiation. We identified two models of age-dependent changes in gene expression, directional changes and increased variance, which contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and implicated downregulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal detectable in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue and that their emergent aging phenotype both endows cells with the ability to become cancer-cells-of-origin and embodies a biosensor that presages cancer susceptibility.

cancer biology↗

bioRxiv2022

Glucose-regulated O-GlcNAcylation of DNMT1 inhibits DNA methyltransferase activity and maintenance of genomic methylation

The DNA methyltransferase activity of DNMT1 is vital for genomic maintenance of DNA methylation. We report here that DNMT1 function is regulated by O-GlcNAcylation, a protein modification that is sensitive to glucose levels, and that elevated O-GlcNAcylation of DNMT1 from high glucose environment leads to alterations to the epigenome. Using mass spectrometry and complementary alanine mutation experiments, we identified S878 as the major residue that is O-GlcNAcylated on DNMT1. Functional studies further revealed that O-GlcNAcylation of DNMT1-S878 results in an inhibition of methyltransferase activity, resulting in a general loss of DNA methylation that is preferentially at partially methylated domains (PMDs). This loss of methylation corresponds with an increase in DNA damage and apoptosis. These results establish O-GlcNAcylation of DNMT1 as a mechanism through which the epigenome is regulated by glucose metabolism and implicates a role for glycosylation of DNMT1 in metabolic diseases characterized by hyperglycemia.

molecular biology↗

bioRxiv2021

Epigenetic changes with age primes mammary luminal epithelia for cancer initiation

Aging causes molecular changes that manifest as stereotypical phenotypes yet aging-associated diseases progress only in certain individuals. At lineage-specific resolution, we show how stereotyped and variant responses are integrated in mammary epithelia. Age-dependent directional changes in gene expression and DNA methylation (DNAm) occurred almost exclusively in luminal cells and implicated genome organizers SATB1 and CTCF. DNAm changes were robust indicators of aging luminal cells, and were either directly (anti-)correlated with expression changes or served as priming events for subsequent dysregulation, such as demethylation of ESR1-binding regions in DNAm-regulatory CXXC5 in older luminal cells and luminal-subtype cancers. Variance-driven changes in the transcriptome of both luminal and myoepithelial lineages further contributed to age-dependent loss of lineage fidelity. The pathways affected by transcriptomic and DNAm changes during aging are commonly linked with breast cancer, and together with the differential variability found across individuals, influence aging-associated cancer susceptibility in a subtype-specific manner.

cancer biology↗

bioRxiv2020

Aging leads to stochastic loss of silencing at transposons in mammary luminal epithelial cells

Luminal epithelial cells (LEps) are a key cell lineage implicated in age-related luminal breast cancers. Alterations to the epigenome are a hallmark of aging cells. However, the extent of age-associated DNA methylation alterations in LEps, and the corresponding functional consequences of these alterations, have remained unclear. We report here that aging leads to distinct methylation changes in LEps. Luminal lineage-specific genes gain promoter methylation, whereas myoepithelial-specific genes lose promoter methylation. Regulatory elements display methylation changes at lineage-specific TF binding sites consistent with the loss of lineage fidelity. CpG islands (CGIs) and transposable elements (TEs) have stochastic methylation gain and loss, respectively. PRC2 target genes that are hypermethylated in luminal breast cancer exhibit stochastic methylation increase with age. TEs with stochastic methylation loss are activated in breast cancer and potentially function as regulatory elements contributing to the loss of lineage fidelity with age. Each of these classes of methylation changes impact the regulation of genes associated with luminal breast cancer. Altogether, our results indicate that aging leads to DNA methylation changes that could determine breast cancer susceptibility. SignificanceMammary luminal epithelial cells lose lineage-specific expression with age and accumulate stochastic methylation changes that lead to loss of silencing at transposable elements. These age-dependent events potentially promote breast cancer susceptibility.

genomics↗

bioRxiv2019

Histone chaperone Nucleophosmin regulates transcription of key genes involved in oral tumorigenesis.

Nucleophosmin (NPM1) is a multifunctional histone chaperone that can activate RNA Polymerase II-driven chromatin transcription. Acetylation of NPM1 by acetyltransferase p300 has been shown to further enhance its transcription activation potential. Moreover, its total and acetylated pools are increased in oral squamous cell carcinoma. However, the role of NPM1 or its acetylated form (AcNPM1) in transcriptional regulation in cells is not fully elucidated. Using ChIP-seq analyses, we show that AcNPM1 co-occupies marks of active transcription at promoters and DNase I hypersensitive sites at enhancers. Moreover, NPM1 interacts with proteins involved in transcription, including RNA Pol II, general transcription factors, mediator subunits, histone acetyltransferase complexes, and chromatin remodelers. Moreover, its histone chaperone also contributes to transcriptional activation. We further show that AcNPM1 regulates key genes required for proliferation, migration and invasion potential of oral cancer cells and knockdown of NPM1 mitigates these processes in cells as well as orthotopic tumors in mice. Collectively, these results establish that AcNPM1 functions as a coactivator and regulates the expression of key genes involved in oral tumorigenesis.

biochemistry↗

bioRxiv2018

Hyperinsulinemia promotes aberrant histone acetylation in triple negative breast cancer

Excess levels of insulin relative to glucose in the blood, or hyperinsulinemia, is considered to be a poor prognostic indicator for patients with triple negative breast cancer (TNBC). While this association has been recognized for some time, the mechanistic role of hyperinsulinemia in promoting TNBC remains unclear. We show that insulin treatment leads to genome-wide increase in histone acetylation, in particular at H3K9, through the PI3K/AKT/mTOR pathway in MDA-MB-231 cells. Genome-wide analysis showed that the increase in histone acetylation occurs primarily at gene promoters. In addition, insulin induces higher levels of reactive oxygen species and DNA damage foci in cells. In vivo, hyperinsulinemia also enhances growth of MDA-MB-231 derived tumors through increased histone acetylation. These results demonstrate the impact of hyperinsulinemia on altered gene regulation through chromatin and the importance of targeting hyperinsulinemia-induced processes that lead to chromatin dysfunction in TNBC.

molecular biology↗